MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/qai.0b013e318074eb73

Медицинская библиотека · Journal of acquired immune deficiency syndromes (1999) · 2007

Prevalence of HIV-1 drug resistance in treated patients: a French nationwide study.

Costagliola Dominique, Descamps Diane, Assoumou Lambert, Morand-Joubert Laurence, Marcelin Anne-Geneviève, Brodard Véronique, Delaugerre Constance, Mackiewicz Vincent, Ruffault Annick, Izopet Jacques, Plantier Jean-Christophe, Tamalet Catherine, Yerly Sabine, Saidi Souhaha, Brun-Vezinet Françoise, Masquelier Bernard, Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS) AC11 Resistance Study Group

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Surveillance of HIV-1 drug resistance in antiretroviral-treated patients is important from the public health perspective of the spread of resistance and to evaluate the proportion of patients for whom new drugs are needed.

METHODS

Patients were consecutively included in 28 centers in France and 1 center in Switzerland if they had a viral load measurement performed in June 2004, with a result >or=1,000 copies/mL. Reverse transcriptase, protease, and gp41 genes were sequenced, and resistance mutations were reported as listed on the Web site ( www.iasusa.org). The genotypic resistance results were interpreted by the Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS) and Stanford algorithms.

RESULTS

The 498 patients included had been exposed to 9 (interquartile ratio [IQR]: 6 to 12) antiretroviral drugs. Patients' viruses harbored 4 nucleoside reverse transcriptase inhibitor (IQR: 1 to 6) and 4 protease inhibitor (PI; IQR: 2 to 8) resistance mutations, whereas 44% had at least 1 nonnucleoside reverse transcriptase inhibitor resistance mutation. The frequency of resistance to at least 1 drug was 88% with the ANRS algorithm and 83% with the Stanford algorithm. The frequencies of complete resistance to 1, 2, and 3 classes of drugs were 37%, 15%, and 4%, respectively, with the ANRS algorithm and 27%, 23%, and 24%, respectively, with the Stanford algorithm. The most important differences between algorithms were for PIs. Using the ANRS algorithm and extrapolation on the whole French database, 19% of all treated patients could contribute to the spread of resistance and 4% had complete resistance to 2 classes of antiretroviral drugs.

CONCLUSIONS

The observed patterns of resistance are linked to a long-lasting history of antiretroviral therapy. The frequency of multiresistance can vary according to the interpretation systems.

Для цитирования: Costagliola Dominique, Descamps Diane, Assoumou Lambert, Morand-Joubert Laurence, Marcelin Anne-Geneviève, Brodard Véronique, Delaugerre Constance, Mackiewicz Vincent, Ruffault Annick, Izopet Jacques, Plantier Jean-Christophe, Tamalet Catherine, Yerly Sabine, Saidi Souhaha, Brun-Vezinet Françoise, Masquelier Bernard, Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS) AC11 Resistance Study Group. Prevalence of HIV-1 drug resistance in treated patients: a French nationwide study.. Journal of acquired immune deficiency syndromes (1999). 2007. DOI: 10.1097/qai.0b013e318074eb73.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.